Feb 25, 2026 11:05AM
Feb 25, 2026 11:05AM
Feb 13, 2026 04:30PM
Feb 13, 2026 04:30PM
Feb 5, 2026 09:15AM
Jan 29, 2026 09:15AM
Jan 29, 2026 09:15AM Longeveron® Granted Japan Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
Jan 26, 2026 09:15AM
Jan 26, 2026 09:15AM
Dec 29, 2025 09:15AM
Dec 17, 2025 09:15AM
Dec 17, 2025 09:15AM
Dec 3, 2025 09:15AM
Dec 3, 2025 09:15AM Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum
Dec 2, 2025 09:15AM
Dec 2, 2025 09:15AM
Dec 1, 2025 12:02PM
Dec 1, 2025 12:00PM
Nov 19, 2025 09:15AM
Nov 19, 2025 09:15AM
Nov 12, 2025 09:05AM Longeveron receives US patent for stem cell therapy treating frailty
Nov 12, 2025 09:05AM
Nov 4, 2025 04:05PM
Oct 28, 2025 09:15AM
Oct 27, 2025 09:15AM
Oct 6, 2025 09:15AM
Oct 1, 2025 04:05PM
Oct 1, 2025 04:05PM George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron® Board of Directors
Sep 22, 2025 09:15AM
Sep 3, 2025 04:05PM
Sep 3, 2025 04:05PM
Aug 20, 2025 09:15AM
Aug 13, 2025 04:05PM
Aug 11, 2025 04:15PM
Aug 11, 2025 04:15PM Longeveron Announces Closing Of Up To $17.5 Million Public Offering
Aug 8, 2025 01:28PM
Aug 8, 2025 01:28PM
Aug 5, 2025 09:15AM
Jul 21, 2025 09:15AM
Jul 21, 2025 09:15AM
Jul 8, 2025 09:15AM
Jul 8, 2025 09:15AM Longeveron® Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy (DCM)
Jun 26, 2025 09:05AM
Jun 26, 2025 09:05AM
Jun 24, 2025 06:31AM
Jun 24, 2025 06:30AM
Jun 9, 2025 09:15AM
May 20, 2025 09:15AM
May 8, 2025 04:05PM Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update
May 2, 2025 08:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All